Graeme Bell serves as Executive at Anacor Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Graeme Bell has executed 7 insider transactions totaling $74.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 28, 2018 involved exercising options for 8,000 shares valued at $107.8K.
Graeme Bell currently holds 21,400 shares of Anacor Pharmaceuticals, Inc. (ANAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Graeme Bell has been a net seller of ANAC stock. They have purchased $0 and sold $74.6K worth of shares.
Graeme Bell's most recent insider trade was on Mar 28, 2018, when they sold 8,000 shares at $13.48 per share.
Get notified when new Form 4 filings are submitted
| 5,000 |
| $22.04 |
| Discretionary |
| Jun 2, 2017 | NTLA | $103.9K | Award | 8,400 | $12.37 | Discretionary |
| Jun 24, 2016 | ANAC | $1.0M | Disposition | 10,488 | $99.25 | Discretionary |
| Jun 1, 2016 | ANAC | $74.6K | Sale | 751 | $99.28 | Discretionary |
| Feb 3, 2016 | ANAC | $0 | Award | 5,000 | $N/A | Discretionary |
| Jun 1, 2015 | ANAC | $0 | Award | 6,006 | $N/A | Discretionary |